A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer

✍ Scribed by Renouf, D.J.; Tang, P.A.; Hedley, D.; Chen, E.; Kamel-Reid, S.; Tsao, M.S.; Tran-Thanh, D.; Gill, S.; Dhani, N.; Au, H.J.; Wang, L.; Moore, M.J.

• Book ID: 124111573
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 435 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2014.04.008